QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today introduced seamless next-generation sequencing (NGS) solutions for a wide range of hereditary diseases on the GeneReader NGS System, the complete Sample to Insight NGS solution for any lab worldwide.
{iframe}https://www.businesswire.com/news/home/20180625006015/en/QIAGEN-announces-broadening-GeneReader-NGS-System-applications{/iframe}